Dr Iris Depaz appointed Country Medical Lead Sanofi Australia and New Zealand
Sydney – 9 September 2021 – Dr Iris Depaz has been appointed as Country Medical Lead for Sanofi in Australia and New Zealand. She will step into the role retaining her
current position as Head of Medical for Sanofi Pasteur in Australia and New Zealand.
Dr Depaz obtained her PhD in Biomedical Sciences at the University of Queensland and conducted post-doctoral research in the area of neuronal drug metabolism and alcohol dependency. She received her EMBA with Honours from the IMD Business School in Lausanne and was recently recognised as 2021 Best & Brightest amongst her class.
Dr Depaz has held multiple senior medical roles across Australia and oversees. She joined Sanofi in 2015, originally as Global Head of the MSL Center for Excellence based in Lyon, France. She became Sanofi Pasteur’s Head of Medical for Australia and New Zealand in 2021.
As Country Medical Lead, Dr Depaz will oversee Sanofi’s local Real World Evidence, Medical Information, and Medical Meetings and Transparency teams. She will also steer
relevant whole of Medical team initiatives supporting medical teams embedded in each of Sanofi’s pharmaceutical and vaccines business units.
Speaking about the appointment, Karen Hood Country Lead for Sanofi Australia and New Zealand said: “Dr Depaz is an incredibly talented and highly regarded medical leader both within Sanofi and beyond.”
“Since having her join our team here at Sanofi Australia and New Zealand I have been impressed by her depth of medical and senior corporate leadership experience. I look
forward to working closely with her in her new capacity as Country Medical Lead.”